José Luis Nájera
About
José Luis Nájera is a scholar working on Virology, Epidemiology and Immunology.
According to data from OpenAlex, José Luis Nájera has authored 27 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Virology, 18 papers in Epidemiology and 16 papers in Immunology. Recurrent topics in José Luis Nájera's work include Herpesvirus Infections and Treatments (13 papers), Immunotherapy and Immune Responses (12 papers) and HIV Research and Treatment (11 papers). José Luis Nájera is often cited by papers focused on Herpesvirus Infections and Treatments (13 papers), Immunotherapy and Immune Responses (12 papers) and HIV Research and Treatment (11 papers). José Luis Nájera collaborates with scholars based in Spain, Switzerland and France. José Luis Nájera's co-authors include Mariano Estéban, Carmen Gómez, Magdalena Krupa, Carlos Óscar S. Sorzano, María Magdalena Gherardi, Juan García‐Arriaza, Eva Pérez-Jiménez, Victoria Jiménez, Beatriz Perdiguero and Susana Guerra and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and PLoS ONE.
In The Last Decade
José Luis Nájera
27 papers receiving 1.2k citations
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| José Luis Nájera Spain | 21 | 825 | 592 | 590 | 376 | 272 | 27 | 1.2k | ||
| Rebecca P. Sumner United Kingdom | 18 | 637 0.8× | 585 1.0× | 504 0.9× | 358 1.0× | 293 1.1× | 26 | 1.2k | ||
| John W. Balliet United States | 18 | 757 0.9× | 476 0.8× | 632 1.1× | 279 0.7× | 181 0.7× | 21 | 1.3k | ||
| Maja A. Sommerfelt Norway | 17 | 983 1.2× | 622 1.1× | 403 0.7× | 396 1.1× | 280 1.0× | 43 | 1.6k | ||
| Ali Javadian United States | 12 | 414 0.5× | 478 0.8× | 366 0.6× | 318 0.8× | 182 0.7× | 13 | 1.0k | ||
| Valgerður Andrésdóttir Iceland | 19 | 717 0.9× | 238 0.4× | 603 1.0× | 407 1.1× | 353 1.3× | 42 | 1.2k | ||
| Jan zur Megede United States | 19 | 587 0.7× | 557 0.9× | 302 0.5× | 377 1.0× | 109 0.4× | 32 | 1.1k | ||
| Keith Limbach United States | 22 | 599 0.7× | 382 0.6× | 422 0.7× | 448 1.2× | 318 1.2× | 32 | 1.2k | ||
| Simoy Goldstein United States | 19 | 1.2k 1.4× | 653 1.1× | 572 1.0× | 196 0.5× | 141 0.5× | 27 | 1.4k | ||
| Mark Martinez United States | 11 | 850 1.0× | 224 0.4× | 624 1.1× | 643 1.7× | 238 0.9× | 15 | 1.1k | ||
| Jerry R. Sisler United States | 11 | 1.2k 1.4× | 342 0.6× | 976 1.7× | 638 1.7× | 427 1.6× | 12 | 1.6k |
Countries citing papers authored by José Luis Nájera
Since
Specialization
Citations
This map shows the geographic impact of José Luis Nájera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by José Luis Nájera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites José Luis Nájera more than expected).
Fields of papers citing papers by José Luis Nájera
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by José Luis Nájera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by José Luis Nájera. The network helps show where José Luis Nájera may publish in the future.
Co-authorship network of co-authors of José Luis Nájera
This figure shows the co-authorship network connecting the top 25 collaborators of José Luis Nájera. A scholar is included among the top collaborators of José Luis Nájera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with José Luis Nájera. José Luis Nájera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Sánchez-Sampedro, Lucas, Ernesto Mejías‐Pérez, Carlos Óscar S. Sorzano, José Luis Nájera, & Mariano Estéban. (2016). NYVAC vector modified by C7L viral gene insertion improves T cell immune responses and effectiveness against leishmaniasis. Virus Research. 220. 1–11.
2.
Fernández‐Escobar, Mercedes, José Luis Nájera, Sara Baldanta, et al.. (2015). Suppression of NYVAC Infection in HeLa Cells Requires RNase L but Is Independent of Protein Kinase R Activity. Journal of Virology. 90(4). 2135–2141.
3.
Perdiguero, Beatriz, Carmen Gómez, José Luis Nájera, et al.. (2012). Deletion of the Viral Anti-Apoptotic Gene F1L in the HIV/AIDS Vaccine Candidate MVA-C Enhances Immune Responses against HIV-1 Antigens. PLoS ONE. 7(10). e48524–e48524.
4.
Gómez, Carmen, Beatriz Perdiguero, José Luis Nájera, et al.. (2012). Removal of Vaccinia Virus Genes That Block Interferon Type I and II Pathways Improves Adaptive and Memory Responses of the HIV/AIDS Vaccine Candidate NYVAC-C in Mice. Journal of Virology. 86(9). 5026–5038.
5.
Gómez, Carmen, José Luis Nájera, Beatriz Perdiguero, et al.. (2011). The HIV/AIDS Vaccine Candidate MVA-B Administered as a Single Immunogen in Humans Triggers Robust, Polyfunctional, and Selective Effector Memory T Cell Responses to HIV-1 Antigens. Journal of Virology. 85(21). 11468–11478.
6.
García‐Arriaza, Juan, José Luis Nájera, Carmen Gómez, et al.. (2011). A Candidate HIV/AIDS Vaccine (MVA-B) Lacking Vaccinia Virus Gene C6L Enhances Memory HIV-1-Specific T-Cell Responses. PLoS ONE. 6(8). e24244–e24244.
7.
Mónaco, Daniela C., Ana M. Rodríguez, María Fernanda Pascutti, et al.. (2011). T-Cell Immune Responses Against Env from CRF12_BF and Subtype B HIV-1 Show High Clade-Specificity that Can Be Overridden by Multiclade Immunizations. PLoS ONE. 6(2). e17185–e17185.
8.
Gómez, Carmen, José Luis Nájera, Magdalena Krupa, Beatriz Perdiguero, & Mariano Estéban. (2011). MVA and NYVAC as Vaccines against Emergent Infectious Diseases and Cancer. Current Gene Therapy. 11(3). 189–217.
9.
García‐Arriaza, Juan, José Luis Nájera, Carmen Gómez, Carlos Óscar S. Sorzano, & Mariano Estéban. (2010). Immunogenic Profiling in Mice of a HIV/AIDS Vaccine Candidate (MVA-B) Expressing Four HIV-1 Antigens and Potentiation by Specific Gene Deletions. PLoS ONE. 5(8). e12395–e12395.
10.
Krupa, Magdalena, Marta Cañamero, Carmen Gómez, et al.. (2010). Immunization with recombinant DNA and modified vaccinia virus Ankara (MVA) vectors delivering PSCA and STEAP1 antigens inhibits prostate cancer progression. Vaccine. 29(7). 1504–1513.
11.
Nájera, José Luis, Carmen Gómez, Juan García‐Arriaza, Carlos Óscar S. Sorzano, & Mariano Estéban. (2010). Insertion of Vaccinia Virus C7L Host Range Gene into NYVAC-B Genome Potentiates Immune Responses against HIV-1 Antigens. PLoS ONE. 5(6). e11406–e11406.
12.
Rodríguez, Ana M., Gabriela Turk, María Fernanda Pascutti, et al.. (2009). Characterization of DNA and MVA vectors expressing Nef from HIV-1 CRF12_BF revealed high immune specificity with low cross-reactivity against subtype B. Virus Research. 146(1-2). 1–12.
13.
Gómez, Carmen, et al.. (2009). Multimeric soluble CD40 ligand (sCD40L) efficiently enhances HIV specific cellular immune responses during DNA prime and boost with attenuated poxvirus vectors MVA and NYVAC expressing HIV antigens. Vaccine. 27(24). 3165–3174.
14.
Mooij, Petra, Sunita S. Balla-Jhagjhoorsingh, Gerrit Koopman, et al.. (2008). Differential CD4+versus CD8+T-Cell Responses Elicited by Different Poxvirus-Based Human Immunodeficiency Virus Type 1 Vaccine Candidates Provide Comparable Efficacies in Primates. Journal of Virology. 82(6). 2975–2988.
15.
Gómez, Carmen, José Luis Nájera, Magdalena Krupa, & Mariano Estéban. (2008). The Poxvirus Vectors MVA and NYVAC as Gene Delivery Systems for Vaccination Against Infectious Diseases and Cancer. Current Gene Therapy. 8(2). 97–120.
16.
Gómez, Carmen, José Luis Nájera, Eva Pérez-Jiménez, et al.. (2006). Head-to-head comparison on the immunogenicity of two HIV/AIDS vaccine candidates based on the attenuated poxvirus strains MVA and NYVAC co-expressing in a single locus the HIV-1BX08 gp120 and HIV-1IIIB Gag-Pol-Nef proteins of clade B. Vaccine. 25(15). 2863–2885.
17.
Gómez, Carmen, José Luis Nájera, Victoria Jiménez, et al.. (2006). Generation and immunogenicity of novel HIV/AIDS vaccine candidates targeting HIV-1 Env/Gag-Pol-Nef antigens of clade C. Vaccine. 25(11). 1969–1992.
18.
Nájera, José Luis, et al.. (2006). Cellular and Biochemical Differences between Two Attenuated Poxvirus Vaccine Candidates (MVA and NYVAC) and Role of the C7L Gene. Journal of Virology. 80(12). 6033–6047.
19.
Guerra, Susana, Luis A. López‐Fernández, Alberto Pascual-Montano, et al.. (2005). Host Response to the Attenuated Poxvirus Vector NYVAC: Upregulation of Apoptotic Genes and NF-κB-Responsive Genes in Infected HeLa Cells. Journal of Virology. 80(2). 985–998.
20.
Gherardi, María Magdalena, Eva Pérez-Jiménez, José Luis Nájera, & Mariano Estéban. (2004). Induction of HIV Immunity in the Genital Tract After Intranasal Delivery of a MVA Vector: Enhanced Immunogenicity After DNA Prime-Modified Vaccinia Virus Ankara Boost Immunization Schedule. The Journal of Immunology. 172(10). 6209–6220.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Rebecca P. Sumner Breakdown of academic impact, for papers by John W. Balliet Breakdown of academic impact, for papers by Maja A. Sommerfelt Breakdown of academic impact, for papers by Ali Javadian Breakdown of academic impact, for papers by Valgerður Andrésdóttir Breakdown of academic impact, for papers by Jan zur Megede Breakdown of academic impact, for papers by Keith Limbach Breakdown of academic impact, for papers by Simoy Goldstein Breakdown of academic impact, for papers by Mark Martinez Breakdown of academic impact, for papers by Jerry R. Sisler